Strategic report Governance & remuneration Financial statements Investor information Pharmaceutical products, competition and intellectual property Patent expiry dates Major Products Compounds Indication s competitor brands USA EU Respiratory 2025 2025 Anoro Ellipta umeclidinium bromide COPD Spiriva, Onbrez NCE NCE vilanterol terfenatate 2016-2030 2016-2026 device device formulation formulation Arnuity Ellipta uticasone furoate asthma Qvar, Pulmicort 2021 2023 Asmanex, NCE NCE Alvesco 2016-2030 2016-2026 device device formulation formulation 3 Avamys Veramyst uticasone furoate rhinitis Nasonex 2021 2023 Flixotide Flovent uticasone propionate asthma COPD Qvar, Singulair 2016 expired Diskus device Diskus device 2015-2025 2017 HFA-device HFA-device Incruse Ellipta umeclidinium bromide COPD Spiriva, Seebri 2025 2025 NCE NCE 2016-2030 2016-2026 device device formulation formulation Relvar Breo uticasone furoate asthma COPD Symbicort, Foster, 2022 2022 Ellipta vilanterol terfenatate US COPD only Flutiform, Dulera NCE NCE 2016-2030 2016-2026 device device formulation formulation Seretide Advair salmeterol xinafoate asthma COPD Symbicort, Foster, 2016 expired uticasone propionate Flutiform, Dulera Diskus device Diskus device 2015-2026 2017 HFA-device HFA-device Serevent salmeterol xinafoate asthma COPD Foradil, Spiriva, 2016 expired Onbrez Diskus device Diskus device 2019 HFA-device Ventolin HFA albuterol sulphate asthma COPD generic companies 2015-2025 2015-2017 HFA-device HFA-device Anti-virals Relenza zanamivir inuenza Tamiu expired expired Valtrex valaciclovir genital herpes, coldsores, Famvir expired expired shingles Zefx Epivir-HBV lamivudine chronic hepatitis B Hepsera expired expired Central nervous system Lamictal lamotrigine epilepsy, bipolar disorder Keppra, Dilantin expired expired Imigran Imitrex sumatriptan migraine Zomig, Maxalt, Relpax expired expired Requip XL ropinirole Parkinsons disease Mirapex expired expired Seroxat Paxil paroxetine depression, various Effexor, Cymbalta, expired expired anxiety disorders Lexapro Cardiovascular and urogenital Eperzan Tanzeum albiglutide Type 2 diabetes Victoza, Byetta 2022 2022 Bydureon, Lyxumia Trulicity 1 Avodart dutasteride benign prostatic hyperplasia Proscar, Flomax, 2015 2017 nasteride 2 Coreg CR carvedilol phosphate mild-to-severe heart failure, Toprol XL 2016 NA hypertension, left ventricular formulation dysfunction post MI Lovaza omega-3 acid ethyl esters very high triglycerides Tricor expired NA See Risk factors on page 233 for details of uncertainty on the timing of follow-on competition.
1 See Note 45 to the financial statements, Legal proceedings.
GSK Annual Report 2014 229 Strategic report Governance & remuneration Financial statements Investor information Pipeline, products and competition continued Pharmaceutical products, competition and intellectual property continued Patent expiry dates Major Products Compounds Indication s competitor brands USA EU Anti-bacterials Augmentin amoxicillin clavulanate common bacterial generic products NA expired potassium infections Oncology Arzerra ofatumumab refractory chronic MabThera Rituxan, 2030 2023 lymphocytic leukaemia Imbruvica Mekinist trametinib BRAF V600 metastatic Yervoy, Opdivo, 2025 NA melanoma Keytruda Promacta eltrombopag idiopathic thrombocytopenic Nplate, 2022 2025 Revolade purpura, hepatitis C MabThera Rituxan associated thrombocytopenia Tanlar dabrafenib BRAF V600 metastatic Yervoy, Zelboraf 2030 not yet granted melanoma Opdivo, Keytruda Tykerb Tyverb lapatanib advanced and metastatic Herceptin, 2020 2023 breast cancer in HER2 Kadcyla positive patients Votrient pazopanib soft tissue sarcoma Yondelis, Sutent, 2023 2025 metastatic renal cell Nexavar, Anitor carcinoma Temsirolimus Rare diseases Volibris ambrisentan pulmonary hypertension Tracleer, Revatio NA 2020 Immuno-inammation Benlysta belimumab systemic lupus erythematosus 2023 2021 Vaccines Boostrix diphtheria, tetanus, acellular booster vaccination Adacel 2017 2017 pertussis Infanrix Pediarix diphtheria, tetanus, pertussis, diphtheria, tetanus, pertussis, Pentacel, Pediacel, NA 2016 polio, hepatitis B, polio, hepatitis B Pentaxim, Pentavac, Haemophilus inuenzae Haemophilus inuenzae Hexaxim type B type B Cervarix HPV 16 & 18 virus like human papilloma virus Gardasil Silgard 2020 2020 particles VLPs, AS04 type 16 and 18 adjuvant MPL aluminium hydroxide Fluarix split inactivated inuenza seasonal inuenza Vaxigrip, Mutagrip, 2022 2022 virus subtypes A and Fluzone, Inuvac, subtype B antigens Aggripal, Fluad, Intenza, Flumist Fluarix Tetra split inactivated inuenza seasonal inuenza Intenza, Flumist QIV, 2022 2022 virus subtypes A and Vaxigrip QIV, subtype B antigens Fluzone QIV, Fluzone High Dose FluLaval split inactivated inuenza seasonal inuenza Vaxigrip, Mutagrip, none none virus subtypes A and Fluzone, Inuvac, subtype B antigens Aggripal, Fluad, Intenza, Flumist Pandemrix derived split inactivated A H1N1 v2009 inuenza Focetria, Celvapan, NA 2020 inuenza virus antigen, prophylaxis AS03 adjuvant Prepandrix derived split inactivated pandemic H5N1 Aunov, Vepacel not yet granted 2026 inuenza virus antigen, inuenza prophylaxis AS03 adjuvant Synorix conjugated pneumococcal invasive pneumococcal Prevenar Prevnar NA 2021 polysaccharide disease, pneumonia acute otitis media 230 GSK Annual Report 2014 Strategic report Governance & remuneration Financial statements Investor information Pharmaceutical products, competition and intellectual property continued 3 Major Patent expiry dates Products Compounds Indication s competitor brands USA EU HIV 1 1 Epzicom Kivexa lamivudine and abacavir HIV AIDS Truvada, Atripla 2016 2019 Stribild combination combination Complera Eviplera 1 Lexiva Telzir fosamprenavir HIV AIDS Prezista, Kaletra, 2018 2019 Reyataz Selzentry maraviroc HIV AIDS Isentress, Intelence, 2021 2022 Prezista Tivicay dolutegravir HIV AIDS Isentress, Prezista 2027 2026 Reyataz, Kaletra Triumeq dolutegravir, lamivudine HIV AIDS Truvada, Atripla 2027 2026 and abacavir Stribild Complera Eviplera 1,2 Trizivir lamivudine, zidovudine HIV AIDS Truvada, Atripla 2016 2016 and abacavir Stribild combination combination Complera Eviplera 1 See Note 45 to the financial statements, Legal proceedings.
3 Includes Supplementary Protection Certicates and other patent term extensions, where granted.
Consumer Healthcare products and competition Brand Products Application Markets Competition Wellness Panadol and tablets, caplets, infant drops paracetamol-based treatment global except US Reckitt-Benckisers Nurofen Panadol Cold for headache, joint pain, Bayers Aspirin & Flu fever, cold symptoms Johnson & Johnsons Tylenol Retailer own label ENO effervescent immediate relief antacid global except US Hypermarcas Estomazil Pzers Gelusil Tums chewable tablets immediate relief antacid US Sanos Rolaids Bayers Alka-Seltzer Retailer own label Nicorette US, lozenges, gum and treatment of nicotine global Novartiss Nicotinell Nicoderm, trans-dermal patch withdrawal as an aid to Johnson & Johnsons Nicorette NiQuitin CQ smoking reduction and except US and Nicabate cessation Retailer own label Oral health Sensodyne toothpastes, toothbrushes treat and prevent dental global Colgate-Palmolives mouth rinse sensitivity and acid erosion Colgate Sensitive Pro Relief Proctor and Gambles Crest Sensi-Relief and Crest Sensi-Stop Strips Polident denture adhesive, denture improve comfort of global Procter & Gambles Fixodent Poligrip cleanser tted dentures and to Reckitt-Benckisers Kukident Corega clean dentures and Steradent Aquafresh toothpastes, toothbrushes prevention of caries, gum global Colgate-Palmolives Colgate mouthwashes disease and bad breath Procter & Gambles Crest and Oral-B Nutrition Horlicks malted drinks and foods nutritional Indian sub continent, Mondelezs Bournvita beverages & food UK, Ireland Nestles Milo Skin health Physiogel moisturising, creams, face and body care for dry, Germany, France, Italy, LOreals La Roche Posay lotions and cleansers sensitive and irritated skin Poland, Spain Beiersdorfs Eucerin Pierre Fabres Avene Zovirax topical cream lip care to treat and prevent global Johnson & Johnsons Compeed Abreva the onset of cold sores Carma Labs Carmex Blistex Incorporateds Blistex Retailer own label GSK Annual Report 2014 231
